Connect your AI

Doximity DOCS Impairment charges for facilities consolidation

Impairment charges for facilities consolidation at other companies

Charles River LaboratoriesCRL

——

Other financials

Income statement

Revenue$145.4M+5.1%

Gross profit$126.0M+1.7%

Operating income$24.8M-49.0%

Net income$19.1M-69.4%

EPS (diluted)$0.10-67.7%

Balance sheet

Cash & equivalents$219.2M+4.6%

Total debt$10.2M-17.8%

Total equity$950.8M-12.2%

Total assets$1.1B-11.1%

Cash flow

Operating cash flow$109.5M+11.2%

CapEx-—

Free cash flow$81.6M-17.1%

Valuation

Market cap$3.75B-60.5%

Profitability

Gross margin89.1%-1.1pp

Operating margin33.3%-6.6pp

Net margin30.4%-8.7pp

FCF margin50.6%+2.7pp

Returns & leverage

Return on equity19.3%-3.2pp

Debt / equity0×0.0×

Current ratio6.1×-0.9×

Where this comes from

Reported directly by Doximity in its filing.

Tagged under the XBRL concept us-gaap:ImpairmentOfLongLivedAssetsHeldForUse.

The official record: Doximity’s 10-K, filed May 19, 2026, on SEC EDGAR. View the filing →

Ask your AI about Doximity's impairment charges for facilities consolidation.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Doximity's impairment charges for facilities consolidation?: Doximity (DOCS) reported impairment charges for facilities consolidation of $0 in Q1 2026.